Kendall Capital Management - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Kendall Capital Management ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2022$119
-100.0%
10,115
-11.2%
0.06%
-56.8%
Q3 2022$239,000
-32.5%
11,3950.0%0.14%
-28.7%
Q2 2022$354,000
-25.6%
11,395
-1.6%
0.20%
-15.2%
Q1 2022$476,000
-1.0%
11,585
+4.7%
0.23%
+0.9%
Q4 2021$481,000
+20.0%
11,060
+38.2%
0.23%
+5.1%
Q3 2021$401,000
+44.8%
8,005
+82.1%
0.22%
+39.1%
Q2 2021$277,0004,3950.16%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders